via Adamello 16
Milano, 20139
Italy
European Institute of Oncology (IEO) IRCCS
SARS-CoV-2 vaccine, antibody responses to the bnt162b2 vaccine, SARS-CoV-2 vaccine adverse effects, cancer chemotherapy, cancer immunotherapy, cancer hormone therapy, cancer immunotherapy, cancer biological treatment.
Cancer, solid tumors, age, elderly, phase I, early-phase clinical trial, new drugs, adverse events, Survival, outcome